Ganten Maria-Katharina, Schuessler Maximilian, Bäuerle Tobias, Muenter Marc, Schlemmer Heinz-Peter, Jensen Alexandra, Brand Karsten, Dueck Margret, Dinkel Julien, Kopp-Schneider Annette, Fritzsche Klaus, Stieltjes Bram
Department of Radiology (E010), German Cancer Research Center, INF 280 69120 Heidelberg, Germany.
Department of Medical Physics in Radiology (E020), German Cancer Research Center, Heidelberg, Germany.
Cancer Imaging. 2013 Dec 11;13(4):548-56. doi: 10.1102/1470-7330.2013.0045.
The aim of this study was to characterize and understand the therapy-induced changes in diffusion parameters in rectal carcinoma under chemoradiotherapy (CRT). The current literature shows conflicting results in this regard. We applied the intravoxel incoherent motion model, which allows for the differentiation between diffusion (D) and perfusion (f) effects, to further elucidate potential underlying causes for these divergent reports.
Eighteen patients with primary rectal carcinoma undergoing preoperative CRT were examined before, during, and after neoadjuvant CRT using diffusion-weighted imaging. Using the intravoxel incoherent motion approach, f and D were extracted and compared with postoperative tumor downstaging and volume.
Initial diffusion-derived parameters were within a narrow range (D1 = 0.94 ± 0.12 × 10(-3) mm(2)/s). At follow-up, D rose significantly (D2 = 1.18 ± 0.13 × 10(-3) mm(2)/s; P < 0.0001) and continued to increase significantly after CRT (D3 = 1.24 ± 0.14 × 10(-3) mm(2)/s; P < 0.0001). The perfusion fraction f did not change significantly (f1 = 9.4 ± 2.0%, f2 = 9.4 ± 1.7%, f3 = 9.5 ± 2.7%). Mean volume (V) decreased significantly (V1 = 16,992 ± 13,083 mm(3); V2 = 12,793 ± 8317 mm(3), V3 = 9718 ± 6154 mm(3)). T-downstaging (10:18 patients) showed no significant correlation with diffusion-derived parameters.
Conflicting results in the literature considering apparent diffusion coefficient (ADC) changes in rectal carcinoma under CRT for patients showing T-downstaging are unlikely to be due to perfusion effects. Our data support the view that under effective therapy, an increase in D/ADC can be observed.
本研究旨在描述和理解直肠癌在放化疗(CRT)过程中由治疗引起的扩散参数变化。目前的文献在这方面显示出相互矛盾的结果。我们应用体素内不相干运动模型,该模型能够区分扩散(D)和灌注(f)效应,以进一步阐明这些不同报告背后的潜在原因。
18例接受术前CRT的原发性直肠癌患者在新辅助CRT之前、期间和之后使用扩散加权成像进行检查。采用体素内不相干运动方法,提取f和D,并与术后肿瘤降期和体积进行比较。
初始扩散衍生参数在较窄范围内(D1 = 0.94 ± 0.12 × 10(-3) mm(2)/s)。随访时,D显著升高(D2 = 1.18 ± 0.13 × 10(-3) mm(2)/s;P < 0.0001),并且在CRT后继续显著增加(D3 = 1.24 ± 0.14 × 10(-3) mm(2)/s;P < 0.0001)。灌注分数f没有显著变化(f1 = 9.4 ± 2.0%,f2 = 9.4 ± 1.7%,f3 = 9.5 ± 2.7%)。平均体积(V)显著减小(V1 = 16,992 ± 13,083 mm(3);V2 = 12,793 ± 8317 mm(3),V3 = 9718 ± 6154 mm(3))。T降期(10/18例患者)与扩散衍生参数无显著相关性。
对于显示T降期的患者,文献中关于直肠癌在CRT下表观扩散系数(ADC)变化的相互矛盾结果不太可能是由于灌注效应。我们的数据支持这样的观点,即在有效治疗下,可以观察到D/ADC增加。